Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Biologics Center Offers Quick Responses On Single-Discipline Clarifying Questions
Dec 16 2025
•
By
Sue Sutter
CBER is offering speedy responses to some post-meeting clarification questions.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from United States